Ratings by BMO Capital (Do Kim)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/8/2023 | Scholar Rock | SRRK | Maintain | Outperform (N/A) |
|
Details | ||
| 2/23/2023 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 11/15/2022 | Scholar Rock | SRRK | Maintain | Outperform (N/A) |
|
Details | ||
| 8/2/2022 | Nuvation Bio Inc | NUVB | Downgrade | Market Perform (Outperform) |
2.76 (4.59) |
66.3% | Details | |
| 5/17/2022 | Scholar Rock | SRRK | Maintain | Outperform (N/A) |
|
Details | ||
| 5/6/2022 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 3/22/2022 | Nuvation Bio Inc | NUVB | Maintain | Outperform (Outperform) |
|
Details | ||
| 3/22/2022 | Nuvation Bio Inc | NUVB | Maintain | Outperform (N/A) |
|
Details | ||
| 2/28/2022 | Morphic Therapeutic | MORF | Maintain | Outperform (N/A) |
|
Details | ||
| 11/9/2021 | Scholar Rock | SRRK | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2021 | Halozyme Therapeutics | HALO | Maintain | Outperform (N/A) |
|
Details | ||
| 8/27/2021 | Alnylam Pharmaceuticals | ALNY | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/10/2021 | Halozyme Therapeutics | HALO | Maintain | Outperform (N/A) |
|
Details | ||
| 5/13/2021 | Scholar Rock | SRRK | Maintain | Outperform (N/A) |
|
Details | ||
| 5/13/2021 | TCR2 Therapeutics | TCRR | Maintain | Outperform (N/A) |
|
Details | ||
| 5/11/2021 | Rapt Therapeutics | RAPT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2021 | Constellation Pharmaceuticals | CNST | Maintain | Outperform (N/A) |
|
Details | ||
| 4/30/2021 | Vertex | VRTX | Maintain | Outperform (Outperform) |
|
Details | ||
| 4/30/2021 | Morphic Therapeutic | MORF | Maintain | Outperform (Outperform) |
|
Details | ||
| 4/30/2021 | Alnylam Pharmaceuticals | ALNY | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 4/12/2021 | Affimed Therapeutics | AFMD | Maintain | Outperform (N/A) |
|
Details | ||
| 3/23/2021 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (Outperform) |
|
Details | ||
| 3/18/2021 | Halozyme Therapeutics | HALO | Maintain | Outperform (Outperform) |
|
Details | ||
| 3/11/2021 | TCR2 Therapeutics | TCRR | Maintain | Outperform (N/A) |
|
Details | ||
| 3/10/2021 | Affimed Therapeutics | AFMD | Maintain | Outperform (N/A) |
|
Details | ||
| 3/8/2021 | Nuvation Bio Inc | NUVB | New Coverage | Outperform (N/A) |
10.50 (4.59) |
-56.29% | Details | |
| 3/5/2021 | Schrodinger | SDGR | Maintain | Outperform (Outperform) |
|
Details | ||
| 3/1/2021 | Morphic Therapeutic | MORF | Maintain | Outperform (N/A) |
|
Details | ||
| 2/24/2021 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 2/24/2021 | Halozyme Therapeutics | HALO | Maintain | Outperform (N/A) |
|
Details | ||
| 2/18/2021 | Rigel Pharmaceuticals | RIGL | Maintain | Outperform (N/A) |
|
Details | ||
| 2/12/2021 | Alnylam Pharmaceuticals | ALNY | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/3/2021 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 1/25/2021 | Fate Therapeutics | FATE | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/25/2021 | Schrodinger | SDGR | Maintain | Outperform (N/A) |
|
Details | ||
| 1/25/2021 | Scholar Rock | SRRK | Maintain | Outperform (N/A) |
|
Details | ||
| 1/25/2021 | AbCellera Biologics | ABCL | Maintain | Outperform (N/A) |
|
Details | ||
| 1/25/2021 | Halozyme Therapeutics | HALO | Maintain | Outperform (N/A) |
|
Details | ||
| 1/25/2021 | Constellation Pharmaceuticals | CNST | Upgrade | Outperform (Market Perform) |
34.50 (33.99) |
-1.48% | Details | |
| 1/25/2021 | Alnylam Pharmaceuticals | ALNY | Downgrade | Market Perform (Outperform) |
166.75 (320.66) |
92.3% | Details | |
| 1/12/2021 | Halozyme Therapeutics | HALO | Maintain | Outperform (N/A) |
|
Details | ||
| 1/5/2021 | AbCellera Biologics | ABCL | New Coverage | Outperform (N/A) |
40.24 (3.45) |
-91.43% | Details | |
| 11/24/2020 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 11/23/2020 | Halozyme Therapeutics | HALO | Maintain | Outperform (N/A) |
|
Details | ||
| 11/23/2020 | Schrodinger | SDGR | Maintain | Outperform (N/A) |
|
Details | ||
| 11/12/2020 | Schrodinger | SDGR | Maintain | Outperform (N/A) |
|
Details | ||
| 11/10/2020 | Scholar Rock | SRRK | Maintain | Outperform (N/A) |
|
Details | ||
| 11/9/2020 | Morphic Therapeutic | MORF | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2020 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2020 | Retrophin | RTRX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2020 | Fate Therapeutics | FATE | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/5/2020 | Replimune Group | REPL | Maintain | Outperform (N/A) |
|
Details | ||
| 11/2/2020 | VBI Vaccines | VBIV | Maintain | Outperform (N/A) |
|
Details | ||
| 10/29/2020 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/27/2020 | Scholar Rock | SRRK | Maintain | Outperform (N/A) |
|
Details | ||
| 10/20/2020 | Rapt Therapeutics | RAPT | Maintain | Outperform (N/A) |
|
Details | ||
| 9/17/2020 | Rigel Pharmaceuticals | RIGL | Maintain | Outperform (N/A) |
|
Details | ||
| 9/1/2020 | Checkmate Pharmaceuticals | CMPI | New Coverage | Outperform (N/A) |
15.28 (10.50) |
-31.28% | Details | |
| 9/1/2020 | Akcea Therapeutics, Inc. | AKCA | Downgrade | Market Perform (Outperform) |
11.38 (18.17) |
59.67% | Details | |
| 8/14/2020 | BioXcel Therapeutics | BTAI | Maintain | Outperform (N/A) |
|
Details | ||
| 8/13/2020 | Rapt Therapeutics | RAPT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/10/2020 | Morphic Therapeutic | MORF | Maintain | Outperform (N/A) |
|
Details | ||
| 8/10/2020 | Schrodinger | SDGR | Maintain | Outperform (N/A) |
|
Details | ||
| 8/5/2020 | Constellation Pharmaceuticals | CNST | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/3/2020 | VBI Vaccines | VBIV | Maintain | Outperform (N/A) |
|
Details | ||
| 7/31/2020 | VBI Vaccines | VBIV | Maintain | Outperform (N/A) |
|
Details | ||
| 7/31/2020 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/27/2020 | TCR2 Therapeutics | TCRR | Maintain | Outperform (N/A) |
|
Details | ||
| 7/21/2020 | BioXcel Therapeutics | BTAI | Maintain | Outperform (N/A) |
|
Details | ||
| 7/20/2020 | BioXcel Therapeutics | BTAI | Maintain | Outperform (N/A) |
|
Details | ||
| 7/14/2020 | Rigel Pharmaceuticals | RIGL | Maintain | Outperform (N/A) |
|
Details | ||
| 7/7/2020 | ObsEva | OBSV | Downgrade | Market Perform (Outperform) |
6.15 (0.10) |
-98.37% | Details | |
| 6/8/2020 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 6/2/2020 | Schrodinger | SDGR | Maintain | Outperform (N/A) |
|
Details | ||
| 5/14/2020 | Schrodinger | SDGR | Maintain | Outperform (N/A) |
|
Details | ||
| 5/7/2020 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 5/7/2020 | VBI Vaccines | VBIV | Maintain | Outperform (N/A) |
|
Details | ||
| 5/7/2020 | Constellation Pharmaceuticals | CNST | Maintain | Market Perform (N/A) |
|
Details | ||
| 5/6/2020 | Constellation Pharmaceuticals | CNST | Maintain | Market Perform (N/A) |
|
Details | ||
| 5/6/2020 | Akcea Therapeutics, Inc. | AKCA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/1/2020 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 4/14/2020 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 3/31/2020 | VBI Vaccines | VBIV | Maintain | Outperform (N/A) |
|
Details | ||
| 3/9/2020 | BioXcel Therapeutics | BTAI | Maintain | Outperform (N/A) |
|
Details | ||
| 3/6/2020 | ObsEva | OBSV | Maintain | Outperform (N/A) |
|
Details | ||
| 3/5/2020 | ObsEva | OBSV | Maintain | Outperform (N/A) |
|
Details | ||
| 3/3/2020 | Fate Therapeutics | FATE | Maintain | Market Perform (N/A) |
|
Details | ||
| 3/2/2020 | Schrodinger | SDGR | New Coverage | Outperform (N/A) |
46.38 (12.74) |
-72.53% | Details | |
| 2/25/2020 | Retrophin | RTRX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/25/2020 | Halozyme Therapeutics | HALO | Maintain | Outperform (N/A) |
|
Details | ||
| 1/31/2020 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/31/2020 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/30/2020 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 1/16/2020 | BioXcel Therapeutics | BTAI | Maintain | Outperform (N/A) |
|
Details | ||
| 1/15/2020 | Halozyme Therapeutics | HALO | Maintain | Outperform (N/A) |
|
Details | ||
| 1/14/2020 | Halozyme Therapeutics | HALO | Maintain | Outperform (N/A) |
|
Details | ||
| 1/9/2020 | VBI Vaccines | VBIV | Maintain | Outperform (N/A) |
|
Details | ||
| 1/9/2020 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/9/2020 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 1/9/2020 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/9/2020 | Fate Therapeutics | FATE | Downgrade | Market Perform (Outperform) |
21.01 (1.33) |
-93.67% | Details | |
| 1/9/2020 | Halozyme Therapeutics | HALO | Upgrade | Outperform (Market Perform) |
17.82 (67.37) |
278.06% | Details | |
| 1/9/2020 | Constellation Pharmaceuticals | CNST | Downgrade | Market Perform (Outperform) |
40.81 (33.99) |
-16.71% | Details | |
| 12/20/2019 | Akcea Therapeutics, Inc. | AKCA | Maintain | Outperform (N/A) |
|
Details | ||
| 12/10/2019 | ObsEva | OBSV | Maintain | Outperform (N/A) |
|
Details | ||
| 12/9/2019 | Rigel Pharmaceuticals | RIGL | Maintain | Outperform (N/A) |
|
Details | ||
| 12/9/2019 | Fate Therapeutics | FATE | Maintain | Outperform (N/A) |
|
Details | ||
| 11/25/2019 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 11/25/2019 | Rapt Therapeutics | RAPT | New Coverage | Outperform (N/A) |
20.70 (58.02) |
180.29% | Details | |
| 11/20/2019 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 11/19/2019 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/13/2019 | Morphic Therapeutic | MORF | Maintain | Outperform (N/A) |
|
Details | ||
| 11/13/2019 | Halozyme Therapeutics | HALO | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/12/2019 | TCR2 Therapeutics | TCRR | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2019 | ObsEva | OBSV | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2019 | Constellation Pharmaceuticals | CNST | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2019 | VBI Vaccines | VBIV | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2019 | Akcea Therapeutics, Inc. | AKCA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2019 | Fate Therapeutics | FATE | Maintain | Outperform (N/A) |
|
Details | ||
| 11/5/2019 | Halozyme Therapeutics | HALO | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/4/2019 | Halozyme Therapeutics | HALO | Maintain | Market Perform (N/A) |
|
Details | ||
| 10/31/2019 | Retrophin | RTRX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/22/2019 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/21/2019 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/7/2019 | Akcea Therapeutics, Inc. | AKCA | Maintain | Outperform (N/A) |
|
Details | ||
| 9/30/2019 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/18/2019 | BioXcel Therapeutics | BTAI | Maintain | Outperform (N/A) |
|
Details | ||
| 9/11/2019 | VBI Vaccines | VBIV | Maintain | Outperform (N/A) |
|
Details | ||
| 9/9/2019 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/26/2019 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/23/2019 | Retrophin | RTRX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/22/2019 | Retrophin | RTRX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/13/2019 | Morphic Therapeutic | MORF | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2019 | ObsEva | OBSV | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2019 | Akcea Therapeutics, Inc. | AKCA | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2019 | Fate Therapeutics | FATE | Maintain | Outperform (N/A) |
|
Details | ||
| 8/1/2019 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/31/2019 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 7/23/2019 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 7/22/2019 | Morphic Therapeutic | MORF | New Coverage | Outperform (N/A) |
19.22 (56.99) |
196.51% | Details | |
| 7/18/2019 | ObsEva | OBSV | Maintain | Outperform (N/A) |
|
Details | ||
| 6/17/2019 | VBI Vaccines | VBIV | Maintain | Outperform (N/A) |
|
Details | ||
| 5/23/2019 | Affimed Therapeutics | AFMD | Maintain | Outperform (N/A) |
|
Details | ||
| 5/23/2019 | BioXcel Therapeutics | BTAI | Maintain | Outperform (N/A) |
|
Details | ||
| 5/1/2019 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 4/22/2019 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 4/16/2019 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 4/15/2019 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 4/8/2019 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 3/27/2019 | Affimed Therapeutics | AFMD | Maintain | Outperform (N/A) |
|
Details | ||
| 3/15/2019 | Amgen | AMGN | New Coverage | Outperform (N/A) |
187.35 (205.82) |
9.86% | Details | |
| 3/11/2019 | TCR2 Therapeutics | TCRR | New Coverage | Outperform (N/A) |
18.02 (1.48) |
-91.79% | Details | |
| 2/28/2019 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 2/8/2019 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/6/2019 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/23/2019 | Rigel Pharmaceuticals | RIGL | Maintain | Outperform (N/A) |
|
Details | ||
| 11/27/2018 | Halozyme Therapeutics | HALO | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/9/2018 | Scholar Rock | SRRK | Maintain | Outperform (N/A) |
|
Details | ||
| 11/9/2018 | Constellation Pharmaceuticals | CNST | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2018 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2018 | Affimed Therapeutics | AFMD | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2018 | Halozyme Therapeutics | HALO | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/6/2018 | Akcea Therapeutics, Inc. | AKCA | Maintain | Outperform (N/A) |
|
Details | ||
| 10/25/2018 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/28/2018 | Affimed Therapeutics | AFMD | Maintain | Outperform (N/A) |
|
Details | ||
| 8/14/2018 | Replimune Group | REPL | New Coverage | Outperform (N/A) |
16.91 (12.32) |
-27.14% | Details | |
| 8/13/2018 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 8/13/2018 | Constellation Pharmaceuticals | CNST | New Coverage | Outperform (N/A) |
9.87 (33.99) |
244.38% | Details |
